PHOENIX, Sept. 12th, 2017 /PRNewswire/ -- Toro Management, LLC DBA SYLK® is proud to announce that SYLK®'s Chief Medical Advisor, Dr. Michael Krychman will present an educational poster to over 1,000 health care professionals and menopause specialists at this year's North American Menopause Society (NAMS) Annual Meeting in Philadelphia, Pennsylvania. The NAMS 2017 Annual Meeting is an international four-day medical conference (Oct. 11-14, 2017) dedicated to the health and well-being of women in midlife and beyond.
Dr. Michael Krychman is a doctor of sexual medicine, a board certified obstetrician and gynecologist, and an AASECT certified clinical sexual counselor and author. Dr. Krychman is to present his findings on the disconnect between personal lubricant companies and customers in communicating the requirements of lubricants and the need for FDA 510(k) clearance.
SYLK® Co-owner Mariessa Mahfouz states, "We are very excited to have our Chief Medical Advisor Dr. Krychman present these findings at the NAMS National Meeting this year. Few scientific abstracts and posters are accepted at NAMS and we are very grateful to be a part of this important scientific and prestigious event. We have found that many women and health care professionals are unaware that personal lubricants sold in the United States are mandated to obtain FDA clearance as a Class II Medical Device. Many women are unaware of the importance of this clearance and the effort it takes for a company to obtain this designation. There are numerous products and brands on the market that fail with respect to compliance with the FDA and it is critical to educate the public so that they choose high quality, safe and 510(k) cleared products. They must be empowered to know the difference. SYLK® is FDA cleared and we are committed to providing the highest quality product and educating consumers and health care professionals alike."
Dr. Michael Krychman comments, "It is an honor to present this important research at the NAMS conference. Too often we see a disconnect between product ingredients and patient awareness of safety and efficacy. There are many products which falsely promote natural or non-toxic ingredients and both patient and health care professionals are easily confused. 510(k) clearance for a vaginal product is a step in the correct direction. Patients should be educated on the importance of pH balance, osmolality and choosing a product with high-quality ingredients, like SYLK®, which is a moisturizing lubricant with all natural non-irritating and soothing ingredients."
Toro Management, LLC DBA SYLK® ("The Company") is the exclusive manufacturer and distributor of SYLK® Natural Moisturizing Lubricant in the United States and its other territories. "The Company" owns the exclusive distribution rights in the United States, Canada, Mexico, Brazil, Taiwan, and China for SYLK®. SYLK® is the premium all-natural personal lubricant that has been sold in Australia and New Zealand since the 1980's, and sold in the United Kingdom since the 1990's. In the United States, SYLK® is an FDA cleared Class II Medical Device.
View original content with multimedia:http://www.prnewswire.com/news-releases/toro-management-llc-dba-sylk-proudly-announces-that-sylks-chief-medical-advisor-dr-michael-krychman-will-present-sylk-at-the-north-american-menopause-society-annual-meeting-300517741.html
SOURCE Toro Management LLC DBA SYLK